Enterobacteriaceae Infections

• CLINICAL_TRIALS research · 2026-01-16
  Clinical Trial Update: Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria

  Clinical trial evaluating whether a rectal swab detecting ESBL-E, carbapenemases, and high-level cephalosporinase can predict infections wit…

• CLINICAL_TRIALS research · 2025-05-25
  Clinical Trial Update: Fecal Transplantation to Eradicate Colonizing Emergent Superbugs [Phase 3]

  This clinical trial update describes a Phase 3 study evaluating fecal microbiota transplantation to eradicate colonizing Enterobacteriaceae …

• CLINICAL_TRIALS research · 2018-06-12
  Clinical Trial Update: Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

  A completed clinical trial from the University of Pittsburgh examining risk factors for resistance to piperacillin/tazobactam among ESBL-pro…

• CLINICAL_TRIALS research · 2009-09-25
  Clinical Trial Update: The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children

  An update on a clinical trial investigating the burden and genetic variability of ESBL-producing Enterobacteriaceae infections in Swiss chil…

• CLINICAL_TRIALS research · 2006-11-29
  Clinical Trial Update: Infections Caused by ESbL-Producing Enterobacteriaceae in Italy

  An update on a clinical trial examining infections caused by ESBL-producing Enterobacteriaceae in Italy. The report includes Enterobacteriac…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.